GENESIS Pharma one of the fastest growing Greek biopharmaceutical companies, sponsors the 8th Roundtable with the Government of Greece, entitled: "Leadership Strategy for Security and Prosperity in an Era of Uncertainty", which will be held from May 5th until May 7th 2004 at the Divani Apollon Palace & Spa Hotel. The 8th Roundtable is organised by the Economist with the participation of the Greek government and the opposition leaders and numerous leading speakers from the financial and business environment.

During the conference, distinguished speakers from Greece and abroad will address issues regarding the reinforcement of security and the attainment of prosperity in politics, economy and enterpreneurship. At the same time, special referral to the 2004 Olympic Games will be made, while it should be mentioned that what contributes to the conference's successful outcome is the choice of the main issue: "Leadership Strategy for Security and Prosperity in an Era of Uncertainty" and the fact that this will be the first official encounter of the new Greek government with representatives from the business environment, since its acceptance of duty.

GENESIS Pharma was incorporated in 1997, with the vision to substantially contribute to the treatment of life- threatening diseases. The company focuses on marketing, sales and distribution of specialised products emerging from biotechnology research for rare and chronic diseases. In reinforcing its role in the market, GENESIS Pharma has accomplished strategic alliances with top biopharmaceutical companies and has developed a strong regional presence in Greece and Southeast Europe. Today it represents top American and European companies of cellular and molecular technology such as Amgen, Biogen Idec, Chiron, Cephalon and Shire.